|1.||Visca, Paolo: 4 articles (01/2008 - 08/2005)|
|2.||Lamont, Iain L: 3 articles (06/2014 - 01/2007)|
|3.||Imperi, Francesco: 3 articles (01/2008 - 08/2005)|
|4.||Tiburzi, Federica: 3 articles (01/2008 - 08/2005)|
|5.||Colmer-Hamood, Jane A: 2 articles (02/2012 - 12/2007)|
|6.||Hamood, Abdul N: 2 articles (02/2012 - 12/2007)|
|7.||Thomas, M: 1 article (04/2015)|
|8.||Callaghan, Máire: 1 article (04/2015)|
|9.||Tyrrell, J: 1 article (04/2015)|
|10.||Wright, C: 1 article (04/2015)|
12/01/2012 - "The iron starvation tolerant mutant (IST3) exhibited enhanced pyoverdine-mediated iron uptake in minimal medium which significantly improved its biofilm formation, seed adhesion and competitive root colonization."
05/01/1995 - "aeruginosa, Fur binds to the pvdS promoter and prevents expression of the gene; under conditions of iron starvation, repression is relieved and PvdS is made, reprogramming the cells for pyoverdine synthesis."
12/01/2012 - "Here, we report the identification of a random transposon mutant IST3 of Pseudomonas putida S11 showing tolerance to iron starvation stress condition and increased pyoverdine production. "
09/01/2002 - "GeneChip expression analysis of the iron starvation response in Pseudomonas aeruginosa: identification of novel pyoverdine biosynthesis genes."
10/17/1996 - "Pseudomonas aeruginosa (Pa) strain PAO synthesises a siderophore, pyoverdine (Pvd), when grown under conditions of iron starvation. "
|2.||Cystic Fibrosis (Mucoviscidosis)
05/01/2001 - "Study of pyoverdine type and production by Pseudomonas aeruginosa isolated from cystic fibrosis patients: prevalence of type II pyoverdine isolates and accumulation of pyoverdine-negative mutations."
12/01/2011 - "We have investigated the amounts of pyoverdine in 148 sputum samples from 36 cystic fibrosis patients (30 infected with P. "
05/01/2001 - "PFGE clone C, the most prevalent among cystic fibrosis patients, and found in an aquatic environment, produced type II pyoverdine. "
05/01/2001 - "aeruginosa isolates from cystic fibrosis patients of a German hospital were analyzed by sequential, pulse-field gel electrophoresis (PFGE) and for pyoverdine production and type. "
01/01/2007 - "The occurrence of pyoverdine-defective strains in chronic infections of patients with cystic fibrosis and the extremely high sequence diversity of genes involved in pyoverdine synthesis and uptake indicate that pyoverdine production is subject to high evolutionary pressure. "
01/01/2015 - "As pyoverdine production and severe infections are linked, we will also report on situations where pyoverdines are considered as being P. "
08/01/2014 - "aeruginosa phenotypes best distinguished infection stages: pyoverdine production (31% of new-onset cultures, 48% of intermittent, 69% of chronic) and reduced protease production (31%, 39%, and 65%, respectively). "
01/01/2010 - "The siderophore pyoverdine of Pseudomonas syringae pv. tabaci 6605 is an intrinsic virulence factor in host tobacco infection."
11/01/2007 - "Fourth, cooperative pyoverdin production is also shown to be favoured by kin selection in vivo (caterpillars), and results in more virulent infections. "
01/01/2007 - "In the opportunistic pathogen Pseudomonas aeruginosa, pyoverdine is necessary for infection in several different disease models. "
|4.||Wounds and Injuries (Trauma)
08/01/1997 - "Analysis of epidemic Pseudomonas aeruginosa isolates by isoelectric focusing of pyoverdine and RAPD-PCR: modern tools for an integrated anti-nosocomial infection strategy in burn wound centres."
01/01/2011 - "Associations were assessed between pigment production (pyocyanin and pyoverdin) and production of DNase, elastase, lipase, protease, siderophore, twitching motility, antibiotic resistance patterns and virulence-associated genes in 57 non-duplicate P aeruginosa isolates from wounds, sputum, urine, high vaginal swab (HVS), ear, eye and respiratory tract swabs and aspirates of peritoneum and ulcers. "
|5.||Pancreatic Elastase (Elastase)
|6.||Anti-Bacterial Agents (Antibiotics)
|8.||PQQ Cofactor (Pyrroloquinoline Quinone)
|9.||Virulence Factors (Pathogenicity Factors)
|10.||Salicylic Acid (2 Hydroxybenzoic Acid)